Morgan Stanley
- SEC CIK
- 0000895421
- Latest filing
- Aug 13, 2026
LBPH holding history
Longboard Pharmaceuticals, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LBPH overviewAll 13F holders of LBPHFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −375,256−100.0% | Sold out | Holders |
| Q3 2024 | 375,256 | $12.5M | <0.1% | +296,611+377.2% | Added | Holders |
| Q2 2024 | 78,645 | $2.13M | <0.1% | −4,915−5.9% | Reduced | Holders |
| Q1 2024 | 83,560 | $1.80M | <0.1% | +51,736+162.6% | Added | Holders |
| Q4 2023 | 31,824 | $191.9K | <0.1% | +24,762+350.6% | Added | Holders |
| Q3 2023 | 7,062 | $39.3K | <0.1% | −3,758−34.7% | Reduced | Holders |
| Q2 2023 | 10,820 | $79.4K | <0.1% | +10,651+6,302.4% | Added | Holders |
| Q1 2023 | 169 | $678 | <0.1% | +166+5,533.3% | Added | Holders |
| Q4 2022 | 3 | $10 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 3 | $0 | 0.0% | +3 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −5−100.0% | Sold out | Holders |
| Q1 2022 | 5 | $0 | 0.0% | +4+400.0% | Added | Holders |
| Q4 2021 | 1 | $0 | 0.0% | +1 | New | Holders |